et al. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papilary carcinoma.Eur J Surg Oncol，2006，32：1097-1100.
6 Lavie O，Homreich G. BRCA germline mutations in Jewish women with uterine serous pa pillary CalFcinomI.Gyneeol Oncol,2004,92:8-32.
7 Xie R, Shipley GL.Hypomethylation-induced expression of S100A4 in endometrial carcinoma.Int J Surg Pathoh, 2007,20:1045-1054.
8 Liang SX, Chong L, Chambers SK, et al. Endometrial glandular dyaplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part Ⅱ: molecular features. Int J Surg Pathoh,2004,12:319-331.
9 Santin AD，Diamandis EP，Bellone S，et al.Overexpression of hunan kallilrein-10 (hK10)in uterine serous papillary carcinomas.Am J Obstet Gynecol，2006， 194：1296-1302.
10 Santin AD, Bellone S, Van SS, et al. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma. Cancer, 2005,104:1391-1397.
11 Zheng W, Schwartz PE. Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and currant opinions regarding pathologic and clinical management. Gynecologic Oncology,2005, 96:579-582.
12 Bellone S，Watts K，Cane S, et al.High serum levels of intedeukin-6 in endometrial carcinoma ale associated with uterine serous papillary histology，a highly aggressive and chemotherapy resistant variant of endometrial cancer.Gynecol Oncol，2005, 98：92-98.
13 Colomiere M, Ward AC, Riley C, et al. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas . British Journal of Cancer ,2009，100: 134-144.
14 Jacqueline M, Anna V. Synuclein-γ (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma. Gynecologic Oncology，2009, 114：293-298.
15 Gottfried E, Konecny, Rachana
上一页 [1] [2] [3] [4] [5] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 妇产科论文 >> 正文